Scientific considerations for global drug development
2020
Requiring regional or in-country confirmatory clinical trials before approval of drugs already approved elsewhere delays access to medicines in low- and middle-income countries and raises drug costs. Here, we discuss the scientific and technological advances that may reduce the need for in-country or in-region clinical trials for drugs approved in other countries and limitations of these advances that could necessitate in-region clinical studies.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
3
Citations
NaN
KQI